共 24 条
Programming of CD8 T Cell Quantity and Polyfunctionality by Direct IL-1 Signals
被引:24
作者:
Sarkar, Surojit
[1
,2
,3
,4
]
Yuzefpolskiy, Yevgeniy
[2
,4
]
Xiao, Hanxi
[2
]
Baumann, Florian M.
[5
]
Yim, Soojin
[6
]
Lee, David J.
[6
]
Schenten, Dominik
[7
]
Kalia, Vandana
[1
,2
]
机构:
[1] Univ Washington, Dept Pediat, Div Hematol & Oncol, Seattle, WA 98195 USA
[2] Seattle Childrens Res Inst, Ben Towne Ctr Childhood Canc Res, Seattle, WA 98101 USA
[3] Univ Washington, Dept Pathol, Sch Med, Seattle, WA 98195 USA
[4] Univ Washington, Mol Med & Mech Dis Grad Program, Sch Med, Seattle, WA 98195 USA
[5] QIAGEN Sci, Germantown, MD 20874 USA
[6] Penn State Univ, Huck Inst Life Sci, University Pk, PA 16802 USA
[7] Univ Arizona, Dept Immunobiol, Canc Ctr, Tucson, AZ 85724 USA
关键词:
PATTERN-RECOGNITION RECEPTORS;
ADAPTIVE IMMUNITY;
EXPANSION;
MYD88;
INNATE;
RESPONSES;
D O I:
10.4049/jimmunol.1800906
中图分类号:
R392 [医学免疫学];
Q939.91 [免疫学];
学科分类号:
100102 ;
摘要:
IL-1, generally considered an amplifier of adaptive immune responses, has been proposed for use as adjuvant during immunization with weak immunogens. However, its effects on memory T cell function remain largely undefined. Using the murine model of acute viral infection, in this paper, we show that in addition to augmenting the size of the Ag-specific pool, IL-1 signals act directly on CD8 T cells to promote the quality of effector and memory responses. Ablation of IL-1R1 or MyD88 signaling in T cells led to functional impairment; both the ability to produce multiple cytokines on a per cell basis (polyfunctionality) and the potential for recall proliferation in response to antigenic restimulation were compromised. IL-1 supplementation during priming augmented the expansion of Ag-specific CD8 T cells through the MyD88-IRAK1/4 axis, resulting in a larger memory pool capable of robust secondary expansion in response to rechallange. Together, these findings demonstrate a critical role of the IL-1-MyD88 axis in programming the quantity and quality of memory CD8 T cell responses and support the notion that IL-1 supplementation may be exploited to enhance adoptive T cell therapies against cancers and chronic infections.
引用
收藏
页码:3641 / 3650
页数:10
相关论文